Molecular evolution and balancing selection in the flavin-containing monooxygenase 3 gene (FMO3)

被引:32
|
作者
Allerston, Charles K.
Shimizu, Makiko
Fujieda, Masaki
Shephard, Elizabeth A.
Yamazaki, Hiroshi
Phillips, Ian R.
机构
[1] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England
[2] UCL, Dept Biochem & Mol Biol, London, England
[3] Showa Pharmaceut Univ, Lab Drug Metab & Pharmacokinet, Tokyo, Japan
[4] Hokkaido Univ, Grad Sch Pharmaceut Sci, Sapporo, Hokkaido, Japan
基金
英国惠康基金;
关键词
balancing selection; evolution; flavin-containing monooxygenase; FMO; haplotype; human; linkage disequilibrium; mutation; nucleotide diversity; single-nucleotide polymorphism;
D O I
10.1097/FPC.0b013e328256b198
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Objectives Flavin-containing monooxygenase 3 (FMO3) is involved in the metabolism of foreign chemicals, including therapeutic drugs, and thus mediates interactions between humans and their chemical environment. Loss-of-function mutations in the gene cause the inherited disorder trimethylaminuria, or fish-odour syndrome. The objective was to gain insights into the evolutionary history of FMO3. Methods Genetic diversity within FMO3 was characterized by sequencing 6.3 kb of genomic DNA, encompassing the entire coding sequence, some intronic and 3'-untransiated region, and 3.4 kb of 5'-flanking sequence, in 23 potential trimethylaminuric Japanese, and the same 3.4 kb 5'-flanking region in 45 unaffected Japanese. Mutational relationships among haplotypes were inferred from a reduced-median network. The time depth of the variation and ages of individual mutations were estimated by maximum-likelihood coalescent analysis. Test statistics were used to investigate whether the variation is compatible with neutral evolution. Results Sixteen single-nucleotide polymorphisms (SNPs) were identified, which segregated as seven distinct haplotypes. Estimated ages of the mutations indicate that almost all predated migration out of Africa. Analysis of the heterozygosity of FMO3 SNPs indicates that genetic differentiation among continental populations is low (F(ST)=0.050). Test statistics, based on allele-frequency spectrum, number and diversity of haplotypes, linkage disequilibrium and interspecific sequence comparisons, showed a significant departure from neutral expectations, because of an excess of intermediate-frequency SNPs and haplotypes, a ragged pairwise mismatch distribution and an excess of replacement polymorphisms. Conclusion The results provide evidence that FMO3 has been the subject of balancing selection. Finally, we identify mutations that are potential targets for selection.
引用
收藏
页码:827 / 839
页数:13
相关论文
共 50 条
  • [31] Modulation of human flavin-containing monooxygenase 3 activity by tricyclic antidepressants and other agents: Importance of residue 428
    Adali, O
    Carver, GC
    Philpot, RM
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1998, 358 (01) : 92 - 97
  • [32] Uncoupled human flavin-containing monooxygenase 3 releases superoxide radical in addition to hydrogen peroxide
    Catucci, Gianluca
    Gao, Chongliang
    Rampolla, Giulia
    Gilardi, Gianfranco
    Sadeghi, Sheila J.
    FREE RADICAL BIOLOGY AND MEDICINE, 2019, 145 : 250 - 255
  • [33] Ethnic differences in human flavin-containing monooxygenase 2 (FMO2) polymorphisms:: Detection of expressed protein in African-America
    Whetstine, JR
    Yueh, MF
    Hopp, KA
    McCarver, DG
    Williams, DE
    Park, CS
    Kang, JH
    Cha, YN
    Dolphin, CT
    Shephard, EA
    Phillips, IR
    Hines, RN
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2000, 168 (03) : 216 - 224
  • [34] Molecular and functional characterization of flavin-containing monooxygenases (FMO1-6) in tree shrews
    Uno, Yasuhiro
    Makiguchi, Miaki
    Ushirozako, Genki
    Tsukiyama-Kohara, Kyoko
    Shimizu, Makiko
    Yamazaki, Hiroshi
    COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY, 2024, 277
  • [35] Molecular Cloning, Sequence, and Expression of Mouse Flavin-Containing Monooxygenases 1 and 5 (FMO1 and FMO5)
    Cherrington, Nathan J.
    Falls, J. Greg
    Rose, Randy L.
    Clements, Kieran M.
    Philpot, Richard M.
    Levi, Patricia E.
    Hodgson, Ernest
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 1998, 12 (04) : 205 - 212
  • [36] Bio-indigo production in two different fermentation systems using recombinant Escherichia coli cells harboring a flavin-containing monooxygenase gene (fmo)
    Han, Gui Hwan
    Bang, Seong Eun
    Babu, Bandamaravuri Kishore
    Chang, Man
    Shin, Hyun-Jae
    Kim, Si Wouk
    PROCESS BIOCHEMISTRY, 2011, 46 (03) : 788 - 791
  • [37] Antibodies to a synthetic peptide that react with flavin-containing monooxygenase (HLFMO3) in human hepatic microsomes
    Myers, CR
    Porgilsson, B
    Myers, JM
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 1997, 37 (02) : 61 - 66
  • [38] Xenobiotic biotransforming enzymes in the central nervous system: An isoform of flavin-containing monooxygenase (FMO4) is expressed in rabbit brain
    Blake, BL
    Philpot, RM
    Levi, PE
    Hodgson, E
    CHEMICO-BIOLOGICAL INTERACTIONS, 1996, 99 (1-3) : 253 - 261
  • [39] Evaluation of xenobiotic N- and S-oxidation by variant flavin-containing monooxygenase 1 (FMO1) enzymes
    Furnes, B
    Schlenk, D
    TOXICOLOGICAL SCIENCES, 2004, 78 (02) : 196 - 203
  • [40] Bio-indigo production by two types of fermentation systems using recombinant E. coli cells harboring a flavin-containing monooxygenase gene (fmo)
    Han, Gui Hwan
    Bang, Seong Eun
    Lim, Giobin
    Kim, SiWouk
    JOURNAL OF BIOTECHNOLOGY, 2010, 150 : S369 - S369